Diethylstilbestrol disulfate
Diethylstilbestrol disulfate (brand names Hydroestryl, Idroestril; former developmental code name M.G. 137) is a synthetic, nonsteroidal estrogen of the stilbestrol group and an ester of diethylstilbestrol (DES) that was formerly marketed but is now no longer available.[1] It is described as an antineoplastic agent.[2]
![]() | |
| Clinical data | |
|---|---|
| Trade names | Hydroestryl, Idroestril |
| Other names | M.G. 137 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ECHA InfoCard | 100.005.690 |
| Chemical and physical data | |
| Formula | C18H20O8S2 |
| Molar mass | 428.47 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
References
- Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 396. ISBN 978-1-4757-2085-3.
- Negwer M (1987). Organic-chemical drugs and their synonyms: (an international survey). VCH Publishers. p. 833. ISBN 978-0-89573-552-2.
| ERTooltip Estrogen receptor |
| ||||||
|---|---|---|---|---|---|---|---|
| GPERTooltip G protein-coupled estrogen receptor |
| ||||||
| |||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
